Koban MU, Hartmann M, Amexis G, Franco P, et al. Targeted therapies, novel antibodies, and immunotherapies in advanced non-small cell lung cancer: clinical evidence and drug approval patterns. Clin Cancer Res 2024 Aug 23. doi: 10.1158/1078-0432.CCR-24-0741.
PMID: 39177967